21Shares Ethereum Staking ETF to end CF Benchmarks pricing license effective Aug. 31, 2026
The sponsor, 21Shares US LLC, gave CF Benchmarks notice on June 30, 2026 that it is terminating the licensing agreement for the CME CF Ether-Dollar Reference Rate used to value the trust's shares and calculate its net asset value. The sponsor intends to replace it with a license from FTSE International Limited on or about August 24, 2026, as part of a broader move to a new benchmark provider.
Key points
- Termination of the CF Benchmarks pricing benchmark license is effective August 31, 2026
- Notice to CF Benchmarks was provided June 30, 2026
- Sponsor intends to enter a FTSE International Limited license on or about August 24, 2026, with a one-year initial term that auto-renews
- The benchmark is used daily to value trust shares and calculate net asset value
The filing
Written by AI on Nov 9, 2026, 11:46 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 07, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.